site stats

Drna stock forecast

Web2 equities research analysts have issued 12 month price objectives for Meridian Bioscience's shares. Their VIVO share price forecasts range from $34.00 to $34.00. On average, they anticipate the company's stock price to reach $34.00 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price.

DRNA Stock Price Forecast. Should You Buy DRNA?

WebApr 7, 2024 · The Dicerna Pharmaceuticals stock prediction results are shown below and presented as a graph, table and text information. Dicerna Pharmaceuticals stock … WebMar 28, 2024 · Forecast target price for 03-30-2024: $ 38.72. Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.524%. Pessimistic target … sholley shopping trolleys https://ogura-e.com

NHI - National Health Investors Inc Forecast - CNNMoney.com

WebStock Price Forecast. The 4 analysts offering 12-month price forecasts for CareCloud Inc have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate ... WebStock Price Forecast. The 5 analysts offering 12-month price forecasts for National Health Investors Inc have a median target of 58.00, with a high estimate of 61.00 and a low estimate of 55.00 ... WebStock Price Forecast. The 25 analysts offering 12-month price forecasts for Norfolk Southern Corp have a median target of 252.00, with a high estimate of 289.00 and a low estimate of 177.00. The ... sholley spare parts

VIVO Stock Forecast, Price & News (Meridian Bioscience)

Category:DH - Definitive Healthcare Corp Forecast - CNNMoney.com

Tags:Drna stock forecast

Drna stock forecast

MESO - Mesoblast Ltd Forecast - CNNMoney.com

WebJan 17, 2024 · Wall Street Stock Market & Finance report, prediction for the future: You'll find the Definitive Healthcare Corp. Class A Common Stock share forecasts, stock quote and buy / sell signals below. According to present data Definitive Healthcare Corp. Class A Common Stock's DH shares and potentially its market environment have been … WebMar 22, 2024 · Dicerna Pharmaceuticals (NASDAQ:DRNA) has a recorded net income of -$112.75 million. DRNA has generated -$1.63 earnings per share over the last four …

Drna stock forecast

Did you know?

WebApr 1, 2024 · According to our current DRNA stock forecast, the value of Dicerna Pharmaceuticals shares will rise by 0.00% and reach $ 38.22 per share by April 3, 2024. … WebStock Price Forecast. The 13 analysts offering 12-month price forecasts for Exelon Corp have a median target of 46.00, with a high estimate of 47.00 and a low estimate of 44.00. The median ...

WebThe target price for DRNA stock is $22.43 based on the average of what a group of analyst think DRNA stock could be worth at a future date. This is not a prediction by Public.com … WebApr 10, 2024 · 9 Wall Street research analysts have issued 1 year price targets for Liberty Global's stock. Their LBTYA share price forecasts range from $20.00 to $33.00. On average, they anticipate the company's share …

WebDRNA stock forecast and price target. Find the latest {companyName} DRNA analyst stock forecast, price target, and recommendation trends with in-depth analysis from … WebDicerna Pharmaceuticals, Inc. (DRNA) Quote Overview » More Research » Dicerna Pharmaceuticals, Inc. (DRNA) Price Target Stock Forecast Trades from $ 1 N/A …

WebMay 27, 2024 · SPY $409.39 1.41%. QQQ $320.93 1.66%. MSFT $288.30 1.50%. AI $33.57 21.50%. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the …

WebPRFT Stock 12 Months Forecast. $81.17. (17.08% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Perficient in the last 3 months. The average price target is $81.17 with a high forecast of $93.00 and a low forecast of $70.00. The average price target represents a 17.08% change from the last price of $69.33. sholley uvu.eduWebJul 16, 2024 · Dicerna Pharmaceuticals (NASDAQ:DRNA) has a market capitalization of $2.99 billion and generates $164.31 million in revenue … sholley with seatWebAug 6, 2024 · Dicerna Pharmaceuticals (NASDAQ:DRNA) has observed the following analyst ratings within the last quarter: In the last 3 months, 7 analysts have offered 12 … sholley trolley shopWebShares of Dicerna Pharmaceuticals were surging Thursday after research partner Novo Nordisk said it would acquire the company for $3.3 billion. Dicerna (ticker: DRNA ) … sholleysWebStock Price Forecast. The 12 analysts offering 12-month price forecasts for Definitive Healthcare Corp have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 11.00. The ... sholleys motorcycleWebDRNA stock forecast Our latest prediction for Dicerna Pharmaceuticals Inc's stock price was made on the Aug. 10, 2024 when the stock price was at 22.19$.. In the short term … shollie imagesWebDicerna Stock Skyrockets as Novo Nordisk to Buy Research Partner for $3.3 Billion Shares of Dicerna Pharmaceuticals were surging Thursday after research partner Novo Nordisk said it would acquire ... sholley uk